Clinical Trial VICCBMT1158


A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and other Indications

Principal Investigator(s)

Haydar Frangoul


  • Protocol No. VICCBMT1158
  • Open Date: 10/20/2011
  • Staging: NA
  • Age Group: Both Child and Adult
  • Scope: National
  • Objective: The primary aim of this study is to examine the incidence of neutrophil recovery of >500/mm3 after cord blood transplantation in a multi institution setting using CBUs that are not Food and Drug Administration (FDA) licensed.
  • Disease Sites: Hematologic
  • Therapies: Bone Marrow/Stem Cell Transplant
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University
  • National Clinical Trial ID: NCT01351545
  • Secondary Protocol No: 10-CBA



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.